153 related articles for article (PubMed ID: 7908220)
21. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
Nauck C; Ivancević V; Emrich D; Creutzfeldt W
Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
[TBL] [Abstract][Full Text] [Related]
22. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor imaging in patients with sarcoidosis.
Kwekkeboom DJ; Krenning EP; Kho GS; Breeman WA; Van Hagen PM
Eur J Nucl Med; 1998 Sep; 25(9):1284-92. PubMed ID: 9724378
[TBL] [Abstract][Full Text] [Related]
24. In-111 octreotide imaging in staging of small cell lung cancer.
Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP
Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640
[TBL] [Abstract][Full Text] [Related]
25. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
Ambrosini V; Tomassetti P; Rubello D; Campana D; Nanni C; Castellucci P; Farsad M; Montini G; Al-Nahhas A; Franchi R; Fanti S
Nucl Med Commun; 2007 Jun; 28(6):473-7. PubMed ID: 17460538
[TBL] [Abstract][Full Text] [Related]
26. Uptake of In-111 pentetreotide by pleural plaques.
Lonneux M; Jamar F; Leners N; Pieters T; Pauwels S
Clin Nucl Med; 1998 May; 23(5):298-301. PubMed ID: 9596154
[TBL] [Abstract][Full Text] [Related]
27. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
[TBL] [Abstract][Full Text] [Related]
28. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
Jamar F; Fiasse R; Leners N; Pauwels S
J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
Reisinger I; Bohuslavitzki KH; Brenner W; Braune S; Dittrich I; Geide A; Kettner B; Otto HJ; Schmidt S; Munz DL
J Nucl Med; 1998 Feb; 39(2):224-7. PubMed ID: 9476922
[TBL] [Abstract][Full Text] [Related]
30. Imaging and staging of small-cell lung cancer: is there a future role for octreotide scintigraphy?
Stokkel MP; Kwa BM; Pauwels EK
Br J Clin Pract; 1995; 49(5):235-8. PubMed ID: 7492457
[TBL] [Abstract][Full Text] [Related]
31. Discrepant uptake between 111In-pentetreotide and 99mTc-MDP in bone metastases of small-cell lung cancer.
Meristoudis G; Ilias I; Giannakopoulos V; Batsakis C; Christakopoulou J
Hell J Nucl Med; 2009; 12(3):283-4. PubMed ID: 19936347
[No Abstract] [Full Text] [Related]
32. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
[TBL] [Abstract][Full Text] [Related]
33. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
Lee JD; Kim DI; Lee JT; Chang JW; Park CY
J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine tumors and somatostatin: imaging techniques.
de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor imaging in small cell lung cancer using 111In-DTPA-octreotide: a preliminary study.
Maini CL; Tofani A; Venturo I; Pigorini F; Sciuto R; Semprebene A; Boni S; Giunta S; Lopez M
Nucl Med Commun; 1993 Nov; 14(11):962-8. PubMed ID: 8290168
[TBL] [Abstract][Full Text] [Related]
36. 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis.
Weinmann P; Crestani B; Tazi A; Genereau T; Mal H; Aubier M; Valeyre D; Moretti JL; Le Guludec D; Lebtahi R
J Nucl Med; 2000 Nov; 41(11):1808-12. PubMed ID: 11079487
[TBL] [Abstract][Full Text] [Related]
37. Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies.
Anthony LB; Woltering EA; Espenan GD; Cronin MD; Maloney TJ; McCarthy KE
Semin Nucl Med; 2002 Apr; 32(2):123-32. PubMed ID: 11965607
[TBL] [Abstract][Full Text] [Related]
38. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
[TBL] [Abstract][Full Text] [Related]
39. Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer.
Soresi E; Invernizzi G; Boffi R; Possa M; Bombardieri E; Ciavarella GP; Liuzzi A
Lung Cancer; 1997 Jul; 17(2-3):231-8. PubMed ID: 9237158
[TBL] [Abstract][Full Text] [Related]
40. [Detection of somatostatin receptors in tumors in the area of the head and neck and their clinical importance].
Kau RJ; Wagner-Manslau C; Saumweber DM; Arnold W
Laryngorhinootologie; 1994 Jan; 73(1):21-6. PubMed ID: 7908199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]